Geneos Wealth Management’s CryoPort CYRX Stock Holding History

Geneos Wealth Management’s Portfolio CYRX Stock Details CYRX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$414K	Sell	50,000 -10,000	-17%	-$90.3K	0.01%	752
2025 Q4	$576K	Hold	60,000	–	–	0.01%	630
2025 Q3	$569K	Hold	60,000	–	–	0.01%	617
2025 Q2	$448K	Sell	60,000 -60,000	-50%	-$372K	0.01%	744
2025 Q1	$730K	Buy	120,000 +60,000	+100%	+$415K	0.01%	768
2024 Q4	$467K	Hold	60,000	–	–	0.02%	608
2024 Q3	$487K	Hold	60,000	–	–	0.02%	574
2024 Q2	$415K	Buy	+60,000	New	+$808K	0.02%	539
2021 Q4	–	Sell	-877	Closed	-$57K	–	2789
2021 Q3	$57K	Hold	877	–	–	﹤0.01%	1416
2021 Q2	$54K	Hold	877	–	–	﹤0.01%	1435
2021 Q1	$49K	Hold	877	–	–	﹤0.01%	1641
2020 Q4	$45K	Buy	877 +163	+23%	+$7.76K	﹤0.01%	1499
2020 Q3	$33K	Buy	714 +255	+56%	+$10.3K	﹤0.01%	1423
2020 Q2	$13K	Buy	+459	New	+$10.2K	﹤0.01%	1795

Other funds holding CYRX

CCM

Cadian Capital Management New York $821M AUM 14.36% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

FAM

Fred Alger Management New York $22.8B AUM 64.63% 1-Year Est. Return

Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return

MCO

MAK Capital One New York $679M AUM 29.02% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Mirova Paris, France $2.46B AUM 11.42% 1-Year Est. Return

Geneos Wealth Management's CYRX Position: Q1 2026 in Review

Geneos Wealth Management reduced its CryoPort (CYRX) stake by 17% in Q1 2026, selling an estimated $90.3K and leaving 50,000 shares worth $414K. The position accounts for 0.01% of the portfolio, ranked #752.

Geneos Wealth Management first reported a position in CYRX in Q2 2020 and has held it in 14 quarters since. The position peaked at $730K in Q1 2025. 165 funds tracked by Wall St. Rank hold CYRX as of Q1 2026.

Geneos Wealth Management held 50,000 shares of CryoPort worth $414K as of Q1 2026.
Geneos Wealth Management sold 10,000 CryoPort shares in Q1 2026, an estimated $90.3K.
CryoPort made up 0.01% of Geneos Wealth Management's portfolio in Q1 2026, its #752 holding.
Geneos Wealth Management first reported a position in CryoPort in Q2 2020 and has held it in 14 quarters since.
Geneos Wealth Management's CryoPort position peaked at $730K in Q1 2025.
165 funds tracked by Wall St. Rank held CryoPort as of Q1 2026.

Based on Geneos Wealth Management's 13F filing for Q1 2026, filed 5 May 2026.